ALUR · Allurion Technologies, Inc.
$0.39
-0.29 (-42.62%)
At close · Mar 9
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's recurring losses from operations incurred since inception, its expectation of continuing operating losses for the foreseeable future, the potential need to raise additional capital to finance its future operations, and noncompliance with certain financial covenants under its credit facilities, the Company has concluded that there is substantial doubt about its ability to continue as a going concern for a period of one year from the date that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q are issued.”View the 10-Q filed May 15, 2026
Market Cap
$2.01M
Shares
1.00M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Dr. Shantanu Gaur | Chief Executive Officer | $2,829,734 |
| Brendan Gibbons | Chief Legal and People Officer | $1,097,663 |
| Ojas Buch | Chief Operating Officer | $989,714 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Benoit Chardon | Former Chief Commercial Officer | $861,517 |
| Dr. Shantanu Gaur | Chief Executive Officer | $661,226 |
| Christopher Geberth | Chief Financial Officer | $542,592 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Dr. Shantanu Gaur | Chief Executive Officer | $2,989,765 |
| Christopher Geberth | Chief Financial Officer | $1,253,457 |
| Benoit Chardon | Former Chief Commercial Officer | $658,992 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michael Davin | Class III member of the Board | Resigned | 2026-08-24 |
| Krishna Gupta | Class I member of the board of directors | Resigned | 2026-08-24 |
| Shantanu K. Gaur, M.D. | member of the Company's board of directors | Resigned | 2026-07-23 |
| Shantanu K. Gaur, M.D. | Chief Executive Officer | Resigned | 2026-07-23 |
| Douglas Hudson | Class II member of the board of directors | Resigned | 2026-07-07 |
| R. Jason Richey | chairperson of the Audit Committee | Resigned | 2026-06-30 |
| R. Jason Richey | Class II member of the board of directors | Resigned | 2026-06-30 |
| Milena Alberti-Perez | chairperson of the Audit Committee of the Board | Resigned | 2025-10-03 |
| Milena Alberti-Perez | Class III member of the board of directors | Resigned | 2025-10-03 |
| R. Jason Richey | Class II director | Appointed | 2025-01-06 |
| Shantanu Gaur | principal financial officer and principal accounting officer | Appointed | 2024-11-13 |
| Christopher Geberth | Chief Financial Officer | Resigned | 2024-11-13 |
| Keith Johns | Class III director | Appointed | 2024-09-04 |
| Milena Alberti-Perez | Class III director | Appointed | 2024-03-15 |
| Benoit Chardon | Chief Commercial Officer | Resigned | 2023-12-15 |
| Osama Alswailem | member of the Compute Health Board | Resigned | 2023-08-07 |
| Benoit Jacques Claude Chardon | Chief Commercial Officer | Appointed | 2023-08-07 |
| Ram Chuttani | Chief Medical Officer | Appointed | 2023-08-07 |
| Shantanu Gaur | Chief Executive Officer and principal executive officer | Appointed | 2023-08-07 |
| Chris Geberth | Chief Financial Officer and principal financial officer and principal accounting officer | Appointed | 2023-08-07 |
| Omar Ishrak | Co-Chairman of the New Allurion board of directors | Appointed | 2023-08-07 |
| Krishna Gupta | Co-Chairman of the New Allurion board of directors | Appointed | 2023-08-07 |
| Nicholas Lewin | director | Appointed | 2023-08-07 |
| Larson Douglas Hudson | director | Appointed | 2023-08-07 |
| Michael Davin | director | Appointed | 2023-08-07 |